Market Overview

Low-Float Du Jour: Genocea Biosciences

Low-Float Du Jour: Genocea Biosciences

Genocea Biosciences (NASDAQ: GNCA) announced Friday that the Journal of Clinical Oncology has selected the company’s GEN-009 clinical results presentation at the 2019 ASCO Annual Meeting as a top 10 featured abstract in immuno-oncology.

Genocea develops cancer immunotherapies and presenting results at ASCO can be meaningful for investors. The stock traded higher by 60 percent at $7.13 per share Friday morning.

This week's trader obsession with the low-float momentum names is important to note. The micro-cap company has about 8 million shares in its float.

Related Links:

Why Stellar Biotech Shares Are Up 70%

Obalon Moves Following Questionable Takeover Rumor

Posted-In: Biotech News Movers Trading Ideas General


Related Articles (GNCA)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Cowen's Pascarelli: CBD Market Shows 'Encouraging Signs'

Watch: The Impact Of The 5% Tariff On Mexican Imports